source
- Rivia unveils AI-driven DataFindings module to accelerate clinical trial data cleaning, Scancell adopts earlySwiss CRO Rivia introduced an AI-powered DataFindings module that integrates with its Rivia Core platform to automate continuous review of clinical trial data. The tool uses AI agents to help user…
- Zura Bio halts hidradenitis suppurativa program after tibulizumab fails phase 2 trialZura Bio announced it is ending development of tibulizumab for hidradenitis suppurativa after the drug did not meet the primary endpoint in a phase 2 study. The trial, called Tibushield, compared t…